EMN
65
-4
SNA
52
-3
PSA
55
2
VIX
24
8
BA
42
-2
PSX
35
-2
WM
76
2
ADM
28
-2
HP
48
18
CMA
33
-3
SYF
65
-2
EXC
37
2
XRAY
11
-5
QCOM
79
-3
CTAS
61
2
AXP
60
3
SBUX
37
-2
DOW
36
-3
TEL
68
-6
YUM
44
-12
EMN
65
-4
SNA
52
-3
PSA
55
2
VIX
24
8
BA
42
-2
PSX
35
-2
WM
76
2
ADM
28
-2
HP
48
18
CMA
33
-3
SYF
65
-2
EXC
37
2
XRAY
11
-5
QCOM
79
-3
CTAS
61
2
AXP
60
3
SBUX
37
-2
DOW
36
-3
TEL
68
-6
YUM
44
-12
Financhill
Back

NovoCure Vs. Surmodics Industry Stock Comparison

Sell
41

NVCR
NovoCure

Last Price:
21.35
Seasonality Move:
5.48%
Sell
48

SRDX
Surmodics

Last Price:
41.97
Seasonality Move:
6.08%
Sell
41
NovoCure (NVCR) is a Sell

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $21.34. The Score for NVCR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Surmodics (SRDX) is a Sell

Is Surmodics a Buy, Sell or Hold?

  • The current Surmodics [SRDX] share price is $41.95. The Score for SRDX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • SRDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $21.34
    The current trend is moderately bullish and NVCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRDX Stock Price Chart

What is Surmodics's stock price today?

  • The Surmodics share price today is $41.95
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRDX is experiencing slight buying pressure.

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.94 Buy
Relative Strength Index (14 RSI): 54.29 Buy
Chaikin Money Flow: 570345 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.17 - 23.43) Sell
Bollinger Bands (100): (12.84 - 19.78) Buy

SRDX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.62 Buy
Relative Strength Index (14 RSI): 79.66 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.16 - 42.2) Buy
Bollinger Bands (100): (27.31 - 36.81) Buy

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.72 Sell
20-day SMA: 22.35 Sell
50-day SMA: 17.65 Buy
200-day SMA: 15.52 Buy
8-day EMA: 21.66 Sell
20-day EMA: 21.27 Buy
50-day EMA: 19.02 Buy
200-day EMA: 21.91 Sell

SRDX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.93 Buy
20-day SMA: 39.46 Buy
50-day SMA: 33.24 Buy
200-day SMA: 32.75 Buy
8-day EMA: 41.66 Buy
20-day EMA: 39.5 Buy
50-day EMA: 35.57 Buy
200-day EMA: 32.51 Buy

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.00 per share, an increase this year of $0.42 per share, and a decrease next year of $0.11 per share.

Surmodics Earnings Growth & SRDX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.37 per share, and an increase next year of $0.30 per share.

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Surmodics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):